Physician profile
Fernando A Lopez
NPI 1285631747
$2,664.19
in general payments reported to CMS, 2019-2025
15 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $527 · 2021: $419 · 2022: $371 · 2023: $448 · 2024: $349 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $458.02 | 2021-2025 | Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $396.28 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $384.64 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| Janssen Pharmaceuticals, INC | $356.38 | 2020-2024 | Xarelto |
| Abbott Laboratories | $272.62 | 2021-2025 | Aveir, Ultreon, Supera |
| Boston Scientific Corporation | $225.79 | 2019-2022 | |
| Abbvie INC. | $132.48 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $113.42 | 2020-2025 | Camzyos |
| Amgen INC. | $90.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.13 | 2025 | Jardiance |
| Edwards Lifesciences Corporation | $49.64 | 2023 | |
| Pbg Puerto Rico LLC | $46.40 | 2020-2025 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $25.00 | 2025 | Mounjaro |
| Bayer Puerto Rico INC. | $21.77 | 2025 | Kerendia |
| Cardinal Health P.R. 120 INC | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.